PHARMACYTE BIOTECH, INC. Stock Repurchased During Period, Shares
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- PHARMACYTE BIOTECH, INC. stock repurchased during period, shares for the quarter ending 2024-04-30 was 8.57M shares.
- PHARMACYTE BIOTECH, INC. stock repurchased during period, shares for the quarter ending 2024-01-31 was 178.83K shares.
- PHARMACYTE BIOTECH, INC. stock repurchased during period, shares for the quarter ending 2023-10-31 was 78.11K shares.
- PHARMACYTE BIOTECH, INC. stock repurchased during period, shares for fiscal 2026 was 0.00 shares, a 100.00% decline from fiscal 2025.
- PHARMACYTE BIOTECH, INC. stock repurchased during period, shares for fiscal 2025 was 1.24M shares, a 85.93% decline from fiscal 2024.
- PHARMACYTE BIOTECH, INC. stock repurchased during period, shares for fiscal 2024 was 8.83M shares.
| Period end | Stock Repurchased During Period, Shares 3 month | Stock Repurchased During Period, Shares 12 month |
|---|---|---|
| 2026-04-30 | 0.00 shares 10-K · filed 2026-07-29 | |
| 2025-04-30 | 1.24M shares 10-K · filed 2026-07-29 | |
| 2024-04-30 | 8.57M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-11 | 8.83M shares 10-K · filed 2025-08-11 |
| 2024-01-31 | 178.83K shares 10-Q · filed 2024-03-18 | |
| 2023-10-31 | 78.11K shares 10-Q · filed 2023-12-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |